Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Other Non-Current Assets (2020 - 2025)

Biofrontera has reported Other Non-Current Assets over the past 6 years, most recently at $360000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 6.01% year-over-year to $360000.0; the TTM value through Dec 2025 reached $360000.0, down 6.01%, while the annual FY2025 figure was $360000.0, 6.01% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $360000.0 at Biofrontera, down from $472000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $1.4 million in Q3 2021 and troughed at $85000.0 in Q3 2022.
  • A 5-year average of $418411.8 and a median of $383000.0 in 2024 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 93.81% in 2022 and later surged 478.82% in 2023.
  • Year by year, Other Non-Current Assets stood at $268000.0 in 2021, then rose by 19.4% to $320000.0 in 2022, then surged by 50.62% to $482000.0 in 2023, then decreased by 20.54% to $383000.0 in 2024, then decreased by 6.01% to $360000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for BFRI at $360000.0 in Q4 2025, $472000.0 in Q3 2025, and $535000.0 in Q2 2025.